Alexander Kastin
Papers
1
Total Citations
103
H-Index
1
About
Alexander Kastin is a leading urologic oncologist whose research has significantly advanced the risk stratification and diagnosis of prostate cancer. His work centers on refining the use of established biomarkers to improve clinical decision-making, particularly in distinguishing aggressive, clinically significant prostate cancer from indolent disease. Kastin’s most influential contribution is his landmark study on the association between PSA density and pathologically significant prostate cancer, which has garnered over 100 citations. This research demonstrated that accounting for prostate volume dramatically enhances the predictive value of PSA, helping to reduce unnecessary biopsies and the over-detection of low-risk tumors. By providing a simple, cost-effective tool for risk assessment, his findings have directly impacted clinical guidelines and daily urologic practice. Kastin’s work is widely recognized for its practical utility, bridging the gap between population-level screening and personalized patient care. His ongoing investigations continue to refine these predictive models, solidifying his reputation as a key figure in the evidence-based evolution of prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1